{"name":"Brexogen Inc.","slug":"brexogen-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOajNUWUk5eC15NFFRRWJ2aEUwRFVac08xcWdJOFRwVDBPa1U1cFFNVVRKYlRNRUdBU1hsRDZQalg0YkZXMlFocVUyT3hVRGgtSjBEaGxvYjhVRjBkaTZHaXJnNjB4Q0FXUjZTS2xmR2RaRUh6VDlYVzZrWkFOTk1NOE13SS12SExTWVVnbkFOaG5rWk82WW00V3NZVEpfNlh4bU5hV3Jn?oc=5","date":"2026-02-27","type":"deal","source":"BioCentury","summary":"Punching above its weight, Korea draws Western partners in CNS - BioCentury","headline":"Punching above its weight, Korea draws Western partners in CNS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNQTBDNVhSZnJvejVySzNIVzNPWHcteUVpV05zaW9ma2JmQmVKOHROaVkzd2JhM2tmdXM5RWFWX3hzdE8tV2JpRFcxYTV5TFFadjdXaHdHRnI0bFFuVTFJX1pOYVg5TVpOWDBkekJ5bkNuV0xNNXBEQXVVd0YtSGNRV0NZSW9OZ3ZXU3dhRnVFaklqVGtMeWZUand1eHVndktZSHBmbmNuYVFyZ2NWbjZmZXE0SWw?oc=5","date":"2025-02-20","type":"deal","source":"BioSpectrum Asia","summary":"First major licensing deal for an exosome therapeutics in Korea - BioSpectrum Asia","headline":"First major licensing deal for an exosome therapeutics in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOcFJ4Sjk0ejFucXpkZDRsSmNPRUxya3Y5NUtVWm9JdVRBRFM1ZTJ5cWJkSDhjTEN0aW1WUTI2RzBsenI2emExa0Y5MnlrSkUzbVl2aVRWVmJ5ZzZyVUpfdy12cmc0TXctWk94bDE1Y0JJVUpISll3bFRvYkZZenJvOGNSVlRTVXZGdkVUVnNoYUVYV1Zicmsya0NrdmtsTUFPaUxlNW0yakFhYl9XeVNScExZN3MzVGxxdG04MXVuQ3daLWdQa29UZDg3VUxQSExiYnoyT3pOZ2NhTEZtNFpTNWh4MA?oc=5","date":"2025-02-19","type":"pipeline","source":"PR Newswire","summary":"Brexogen and BMI Korea Enter Strategic Technology Transfer Agreement for Exosome Therapeutics - PR Newswire","headline":"Brexogen and BMI Korea Enter Strategic Technology Transfer Agreement for Exosome Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOd01idU8wbndkbnlSTTJtMTBtaTVwbnl4dERDQnZYOFV6cmRHMWQ1Y2ZRelVnRlpyOG1UbUJIbm9RSl9GbWJITS1fVjBtcGw0Q194SDBNb2RBczloUzdlV2RXSEx5ZDFYSnpLa3BNeGdST0diMnFzTFJHbnB3dXhhU2h2WjFBTC16YkxEN3ZkY2F0dlg1TjZoOThzcV9Xb0Vr?oc=5","date":"2025-02-19","type":"deal","source":"Contract Pharma","summary":"Brexogen, BMI Korea Ink Exosome Therapy Licensing Deal - Contract Pharma","headline":"Brexogen, BMI Korea Ink Exosome Therapy Licensing Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNMEM0S2RNSkg5N2h3NExOWWF0ZFRkTlBFXzFiN2tfWGIyNUJaWkluQ3NsN3BrVE5xbEdaeHZNMFJkRjgtZVU4RU90eENnbmxSaFIyWjlkM0RGSTYwc1NRQUY3cHZxSGdnekNWR3BKWmZmWXphMHh1NlJlc0poSHBYOGxmdnU0YW9VeS05RDZvMDBkd2pHTVZDc2dwQ2IwdUQ3d1lfTkFENHd2N2ZuazVUQTJ0RUFGQjNXamRkM3JnZnRjVlJEYkJxcjRadVVNTTFWcFNPT2NCOFN4Rjh5ZGRJOVVpSW5TMkNjQ2Q0?oc=5","date":"2025-01-13","type":"trial","source":"PR Newswire","summary":"Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight - PR Newswire","headline":"Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPeThLUHJyLVFiTEZNQV96VlJnRzhXSTh5M1lEanJ6WnE3Sy05RXcyLXRYZGJRbExnSk5BdTdudjhKd1FCMUZjejduNUt0Uy1NTVZ4UEhONjZ0WVNwMmxRNEh6RnNmNm9yZ2NqM2xTZTFJVzQ1RzBaR1RLdFdCRG5FNnZRcldIdU5ic0NvZy11UEk0THR5Vmo2ZDI2VGVyaWhic3Y1Zm1ka2s5ZE1xcDhPd2NVWkUxUGVzc0JIVlFiOVZHejZudmpfRWZVUGlFM2tfcVlnMC1aczV6YjhoUk13NDRVbURFbXVLM1E?oc=5","date":"2024-11-04","type":"pipeline","source":"PR Newswire","summary":"Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - PR Newswire","headline":"Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPd3duWlFZcnJ5VUpJTmRLbVRGTkl2aEVHVk9JZ2lMa2h6YXNCVnQ3a0ZQZnYzVnlFQlhHdmItNGI1NUJQSTdUa0EyZFZRSWJqRTQ0dnZsZTdnZFFhNXZDdVEtNFdWclZfNmZzcE5MYXBlT2JnMmV3NVR4QWhyRlNraWZoSllBYnIxbkkwc0puUE9KWnIxcnc0QmFpeHJUN2dOeWpmTFp2TnNKU1ExZTZBdG1iN1BxWkVsM053OVppNHFkdF84V2dnUkVqQmxpeGR1S2MxZEI2MWhfczZmSnh4XzhyclQ?oc=5","date":"2024-10-29","type":"pipeline","source":"globenewswire.com","summary":"Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - globenewswire.com","headline":"Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5GcUtVNzNJNVRweV9OMGliNHR2aHYzcFI1cTRGcE9JQ1Y4ODFrV2NJV0dqclVkZ0diTXhWaFhacGJpQzZQRWxUeGpoQW1rdDRrMjZKWGZSTUVTdDdlT3BoVDVaTXZOLVhkbGhLd29n0gFyQVVfeXFMTWlEcGhubDFNUjVCVmJleWd5V0lkQXlOSHhqUnZBMXU0SmowejJjTi1kNlhvbXN6dVZzVGRWWFQ2U3c2UXRtbERwbHI5V2FxYUdIc2lzRUhabEt5NXRMRmtLdGtFQUNBVXpWQkZxZmhoUWpn?oc=5","date":"2023-08-31","type":"deal","source":"koreabiomed.com","summary":"HK inno.N signs CMO deal with Brexogen for exosome therapeutic cell lines - koreabiomed.com","headline":"HK inno.N signs CMO deal with Brexogen for exosome therapeutic cell lines","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}